SCHEMBL24435148

SCHEMBL24435148

O=C(Nc1nc(-c2ccccc2)cs1)c1cccn1Cc1ccncc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.61
ROCK1 Q13464 8/20 0.56
PRKACA P17612 1/20 0.56
ROCK2 O75116 4/20 0.54
LMNA P02545 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
HSD17B10 Q99714 2/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
TP53 P04637 1/20 0.53
ALOX15 P16050 1/20 0.53
TSHR P16473 1/20 0.53
MAPK1 P28482 1/20 0.53
HTT P42858 1/20 0.53
POLB P06746 1/20 0.53
MAPT P10636 1/20 0.53
CLK1 P49759 1/20 0.53
MCL1 Q07820 1/20 0.53
ELOVL1 Q9BW60 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30152048 0.88 KDM4E (0.66) LMNAMEN1KMT2AHSD17B10NPC1
SCHEMBL24936715 0.88 KDM4E (0.66) LMNAMEN1KMT2AHSD17B10NPC1
SCHEMBL25394073 0.86 PARP1 (0.45) PARP1ROCK1PRKACAROCK2LMNA
SCHEMBL24434536 0.84 SCN3A (0.48) PARP1ROCK1PRKACAROCK2LMNA
SCHEMBL24435306 0.84 POLB (0.45) PARP1ROCK1PRKACAROCK2LMNA
SCHEMBL24434729 0.84 NPC1 (0.62) MEN1KMT2AHSD17B10NPC1RAB9A
SCHEMBL24434861 0.84 AOC3 (0.48) PARP1ROCK1PRKACAROCK2LMNA
SCHEMBL24434786 0.82 ADORA1 (0.47) PARP1ROCK1ROCK2LMNAMEN1
SCHEMBL24435120 0.82 AOC3 (0.45) LMNAMEN1KMT2AHSD17B10NPC1
SCHEMBL24434682 0.82 SMN1; SMN2 (0.46) LMNAMEN1KMT2AHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3930849-B1 THIAZOLE DERIVATIVES AS PROTEIN SECRETION INHIBITORS KEZAR LIFE SCIENCES (US) 2025-02-19 EP disclosed
US-20220153732-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153732-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G PARP1 4383/4885ROCK1 2147/4885PRKACA 1772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.